Literature DB >> 3651746

A study of Schneider's first-rank symptoms of schizophrenia in Nigerian patients.

O Gureje1, E A Bamgboye.   

Abstract

A prospective evaluation of Schneider's first-rank symptoms in 56 Nigerians with RDC schizophrenia gave a prevalence of 73%. The presence of first-rank symptoms was unrelated to schizophrenic subtypes, duration or severity of illness. While some of the symptoms correlate with age of patients, the pattern of inter-correlations among them supports previous views about their empirical heterogeneity.

Entities:  

Mesh:

Year:  1987        PMID: 3651746     DOI: 10.1192/bjp.150.6.867

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

Review 1.  First rank symptoms for schizophrenia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman; Clare Davenport; Amanda J Kirkham; Sarah Grabowski; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

2.  The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia.

Authors:  Ann K Shinn; Stephan Heckers; Dost Öngür
Journal:  Schizophr Res       Date:  2013-03-22       Impact factor: 4.939

Review 3.  The diagnostic status of first-rank symptoms.

Authors:  Julie Nordgaard; Sidse M Arnfred; Peter Handest; Josef Parnas
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

4.  Schneider's first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis.

Authors:  Fernando R Malinowski; Brazilio de C Tasso; Bruno B Ortiz; Cinthia H Higuchi; Cristiano Noto; Sintia I Belangero; Rodrigo A Bressan; Ary Gadelha; Quirino Cordeiro
Journal:  Braz J Psychiatry       Date:  2020 Jan-Feb       Impact factor: 2.697

5.  Cultural aspects of major mental disorders: a critical review from an Indian perspective.

Authors:  Biju Viswanath; Santosh K Chaturvedi
Journal:  Indian J Psychol Med       Date:  2012-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.